BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31012087)

  • 1. Keratinocyte cancer excisions in Australia: Who performs them and associated costs.
    Thompson BS; Pandeya N; Olsen CM; Dusingize JC; Green AC; Neale RE; Whiteman DC
    Australas J Dermatol; 2019 Nov; 60(4):294-300. PubMed ID: 31012087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and multiplicity rates of keratinocyte cancers in Australia.
    Pandeya N; Olsen CM; Whiteman DC
    Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.
    Claeson M; Pandeya N; Dusingize JC; Thompson BS; Green AC; Neale RE; Olsen CM; Whiteman DC
    JAMA Dermatol; 2020 Dec; 156(12):1324-1332. PubMed ID: 33026421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age group-specific changes in keratinocyte cancer treatment rates in Australia, 2012-2021: a retrospective cohort study based on MBS claims data.
    Olsen CM; Pandeya N; Neale RE; Whiteman DC
    Med J Aust; 2024 May; 220(9):472-479. PubMed ID: 38685827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin cancer excision performance in Scottish primary and secondary care: a retrospective analysis.
    Haw WY; Rakvit P; Fraser SJ; Affleck AG; Holme SA
    Br J Gen Pract; 2014 Aug; 64(625):e465-70. PubMed ID: 25071058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
    Hansen C; Wilkinson D; Hansen M; Soyer HP
    Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
    Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
    Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the healthcare costs of skin cancer in South Africa.
    Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
    BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of facial skin cancers managed in a French ambulatory surgical center.
    Mathieu O; Chaine A; Benassarou M; Combes F; Debelmas A; Lanciaux S; Bertolus C; Bouaoud J
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3):101726. PubMed ID: 38056693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011.
    Olsen CM; Williams PF; Whiteman DC
    J Am Acad Dermatol; 2014 Jul; 71(1):21-6.e1. PubMed ID: 24685358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excision pathways for keratinocyte cancers diagnosed by teledermatology: a retrospective review.
    Tirado-Perez JP; Oakley A; Gansel R
    J Prim Health Care; 2024 Mar; 16(1):90-95. PubMed ID: 38546776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study.
    Ramdas K; van Lee C; Beck S; Bindels P; Noordhoek Hegt V; Pardo L; Versnel S; Nijsten T; van den Bos R
    Dermatology; 2018; 234(3-4):86-91. PubMed ID: 30086541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor skin excisions in general practice in North Queensland.
    Heal C; Buettner P; Raasch B; Browning S
    Aust Fam Physician; 2006 Oct; 35(10):825-8. PubMed ID: 17019461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
    Wilson LS; Pregenzer M; Basu R; Bertenthal D; Torres J; Asgari M; Chren MM
    Dermatol Surg; 2012 Apr; 38(4):570-84. PubMed ID: 22145798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
    Youl PH; Janda M; Aitken JF; Del Mar CB; Whiteman DC; Baade PD
    Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
    Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
    Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.